申请人:ANGION BIOMEDICA CORP.
公开号:US20140329871A1
公开(公告)日:2014-11-06
The present invention provides compounds having the general structural Formula (I):
and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis or dysproliferation.
本发明提供具有一般结构式(I)的化合物及其药学上可接受的衍生物,如本文中一般描述的类别和亚类别中所述,并且还提供其制药组合物和使用方法,用于治疗涉及纤维化或异常增生的许多疾病或病症。